DekaBank Deutsche Girozentrale’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,760	Closed	-$137K	–	1440
2021 Q3	$137K	Hold	2,760	–	–	﹤0.01%	1259
2021 Q2	$190K	Hold	2,760	–	–	﹤0.01%	1227
2021 Q1	$201K	Hold	2,760	–	–	﹤0.01%	1182
2020 Q4	$263K	Hold	2,760	–	–	﹤0.01%	1141
2020 Q3	$379K	Buy	+2,760	New	+$460K	﹤0.01%	975
2019 Q3	–	Sell	-5,600	Closed	-$714K	–	1043
2019 Q2	$714K	Sell	5,600 -600	-10%	-$71.2K	﹤0.01%	859
2019 Q1	$632K	Buy	6,200 +3,400	+121%	+$343K	﹤0.01%	859
2018 Q4	$247K	Sell	2,800 -3,400	-55%	-$345K	﹤0.01%	938
2018 Q3	$632K	Sell	6,200 -150	-2%	-$15.8K	﹤0.01%	880
2018 Q2	$608K	Hold	6,350	–	–	﹤0.01%	866
2018 Q1	$636K	Buy	+6,350	New	+$684K	﹤0.01%	822

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LKFT Position: Q4 2021 in Review

DekaBank Deutsche Girozentrale sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2021, closing a stake of 2,760 shares — an estimated $137K sold.

DekaBank Deutsche Girozentrale first reported a position in LKFT in Q1 2018 and held it in 11 quarters. The position peaked at $714K in Q2 2019. 83 funds tracked by Wall St. Rank hold LKFT as of Q4 2021.

DekaBank Deutsche Girozentrale reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2021 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 2,760 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2021, an estimated $137K.
DekaBank Deutsche Girozentrale first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2018 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's Lakefront Biotherapeutics American Depositary Shares position peaked at $714K in Q2 2019.
83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2021.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.